Hunan Jiudian Pharmaceutical Co Ltd
SZSE:300705

Watchlist Manager
Hunan Jiudian Pharmaceutical Co Ltd Logo
Hunan Jiudian Pharmaceutical Co Ltd
SZSE:300705
Watchlist
Price: 24.75 CNY 3.99% Market Closed
Market Cap: 12.1B CNY
Have any thoughts about
Hunan Jiudian Pharmaceutical Co Ltd?
Write Note

Hunan Jiudian Pharmaceutical Co Ltd
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hunan Jiudian Pharmaceutical Co Ltd
PP&E Gross Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
Hunan Jiudian Pharmaceutical Co Ltd
SZSE:300705
PP&E Gross
ÂĄ1.3B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
PP&E Gross
ÂĄ3.3B
CAGR 3-Years
-2%
CAGR 5-Years
16%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
PP&E Gross
ÂĄ854.4m
CAGR 3-Years
12%
CAGR 5-Years
26%
CAGR 10-Years
11%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
PP&E Gross
ÂĄ7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
PP&E Gross
ÂĄ3.6B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
8%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
PP&E Gross
ÂĄ534.8m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hunan Jiudian Pharmaceutical Co Ltd
Glance View

Market Cap
12B CNY
Industry
Pharmaceuticals

Hunan Jiudian Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products. The company is headquartered in Changsha, Hunan and currently employs 1,450 full-time employees. The company went IPO on 2017-10-10. The Company’s products are comprised of pharmaceutical preparations, raw materials, pharmaceutical excipients and plant extracts, including loxoprofen sodium gel ointment, ornidazole raw materials and preparations, dirithromycin raw materials and preparations, clindamycin phosphate tablets and so on. The products are used for the treatment of bacterial infections and anti-allergy. The firm sells its products to both domestic and international markets, including Europe, South Korea, India, Russia and South America.

Intrinsic Value
35.17 CNY
Undervaluation 30%
Intrinsic Value
Price

See Also

What is Hunan Jiudian Pharmaceutical Co Ltd's PP&E Gross?
PP&E Gross
1.3B CNY

Based on the financial report for Sep 30, 2024, Hunan Jiudian Pharmaceutical Co Ltd's PP&E Gross amounts to 1.3B CNY.

Back to Top